Xenotransplantation (XTx) presents a promising clinical alternative to address the current shortage of human organs,” Luz Padilla, MD, MSPH, of the department of surgery and the department of epidemiology at the University of Alabama at Birmingham, and colleagues wrote in a poster at the American Transplant Congress. “Recently, XTx has been performed using decedent models and under expanded access approval as a prelude to human clinical trials. Before such trials can occur, public assessments are crucial to understand potential barriers to acceptance, as recommended by key regulatory bodies,” they wrote.

Read Full Article Opens an external link.